New Technique Shows Patients taking Brittle Bone Prevention Drugs at Risk for Jaw Necrosis

[Rosemont, IL, May 1, 2016] Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of certain medications used to prevent bone loss in women at high risk of fractures resulting from osteoporosis (brittle bones). The drugs work by decreasing bone breakdown and increasing bone strength and density. Showing which of these patients is at a higher risk for this problem would be a major scientific finding since it would help guide their therapy.

Download Press Release.